Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. uri icon

authors

  • Yulug, Burak
  • Idil, Ezgi
  • Nogaylar, Rahim
  • Ozsimsek, Ahmet
  • Bayram, Cemil
  • Bolat, Ismail
  • Oner, Sena
  • Tozlu, Ozlem Ozdemir
  • Arslan, Mehmet Enes
  • Hacimuftuoglu, Ahmet
  • Yildirim, Serkan
  • Altay, Ozlem
  • Arif, Muhammad
  • Shoaie, Saeed
  • Zhang, Cheng
  • Nielsen, Jens
  • Turkez, Hasan
  • Borén, Jan
  • Uhlén, Mathias
  • Mardinoglu, Adil
  • Li, Xiangyu
  • Hanoglu, Lutfu
  • Cankaya, Seyda
  • Lam, Simon
  • Velioglu, Halil Aziz
  • Yang, Hong
  • Coskun, Ebru

publication date

  • January 26, 2023